<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
    <meta name="description" content="">
    <meta name="author" content="">
    <link rel="icon" href="../../favicon.ico">

    <title>Score-project by JWiley</title>

    <link href="bootstrap.min.css" rel="stylesheet">
    <link href="bootstrap-theme.min.css" rel="stylesheet">    
    <link href="nv.d3.min.css" rel="stylesheet">
    <style>
      .rChart{
      display: block;
      margin-left: auto;
      margin-right: auto;
      width: 450px;
      height: 450px;
      }
    </style>


    <script src="jquery.min.js"></script>
    <script src="bootstrap.min.js"></script>
    <script>
      $(function () {
      $('[data-toggle="tooltip"]').tooltip()
      })
    </script>
    
    <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
    <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
    <![endif]-->
  </head>

  <body>

    <!-- Fixed navbar -->
    <nav class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
            <span class="sr-only">Toggle navigation</span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="http://score-project.org">SCORE Project</a>
        </div>
        <div id="navbar" class="collapse navbar-collapse">
          <ul class="nav navbar-nav">
            <!-- <li class="active"><a href="#">Home</a></li> -->
            <li><a href="#mets" class="btn">MetS</a></li>
            <li><a href="#al" class="btn">Allostatic Load</a></li>	    
            <li><a href="#methods" class="btn">Methods</a></li>
            <li><a href="#pubs" class="btn">Publications</a></li>
	    <li class="dropdown">
              <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Software <span class="caret"></span></a>
              <ul class="dropdown-menu" role="menu">
		<li><a href="#software" class="btn">About the Software</a></li>
                <li class="divider"></li>		
		<li><a href="https://github.com/JWiley/score-project" class="btn">View on GitHub</a></li>
		<li><a href="https://github.com/JWiley/score-project/blob/master/pscore_0.1-2.tar.gz?raw=true" class="btn">Download pscore .tar.gz</a></li>		
		<li><a href="https://github.com/JWiley/score-project/zipball/master" class="btn">Download all .zip</a></li>
		<li><a href="https://github.com/JWiley/score-project/tarball/master" class="btn">Download all .tar.gz</a></li>		

              </ul>
            </li>
	  </ul>
        </div><!--/.nav-collapse -->
      </div>
    </nav>

    <!-- Begin page content -->
    <div class="container">
      <div class="page-header" style="padding-top:20px;">
	<h1>SCORE Project</h1>
	<h2><strong><u>S</u></strong>tandardizing Physiological <strong><u>Co</u></strong>mposite <strong><u>R</u></strong>isk <strong><u>E</u></strong>ndpoints (SCORE)</h2>
      </div>

      <p class="lead">The SCORE Project has a simple goal: help to standardize the creation and use of physiological composite risk endpoints.</p>

      <p>As more research studies collect multiple biomarkers, there is an increasing need to
	"reduce dimensionality" or otherwise summarize related biomarkers into composites,
	often for use as endpoints, but also as predictors.
      </p>
      <p>The field of psychometrics has long dealt with how to use multiple
	(potentially noisy) indicators of an underlying construct,
	like health, or cardio-metabolic risk, or ..., but these
	techniques are not commonly applied to biological data.
	Studies that do collect biomarkers and create composites often have
	slightly different composites, because 	each study assesses a
	different set of biomarkers.  In psychometrics, standard
	scales are developed and people tend to use these scales.  No
	such standardized equivalents exist for biomarkers. 
      </p>
      <p>
	The SCORE Project is all about changing this by
	understanding how biomarkers relate and creating reliable, 
	validated composites that can be used in research or clinical
	practice.
      </p>


      <h2 id="mets">Metabolic Syndrome</h2>
      
	  <p>Metabolic syndrome represents a cluster of risk factors for
	    cardiovascular disease and diabetes that frequently co-occur.
	    Metabolic syndrome comprises:</p>
	  <ul>
	    <li>hypertension (high systolic or diastolic blood pressure)</li>
	    <li>elevated triglycerides</li>
	    <li>low high-density lipoprotein cholesterol</li>
	    <li>hyperglycemia (elevated fasting glucose or glycosylated hemoglobin)</li>
	    <li>central obesity (high body mass index or waist circumference)</li>
	  </ul>
	  
	  <p>Metabolic syndrome is defined as the presence
	    of at least 3/5 risk factors, according to guidelines from a joint scientific
	    statement by the International Diabetes Federation Task Force on Epidemiology and Prevention;
	    National Heart, Lung, and Blood Institute;
	    American Heart Association;
	    World Heart Federation;
	    International Atherosclerosis Society;
	    and International Association for the Study of Obesity
	    (<a data-toggle="tooltip" title="Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., . . . Smith, S. C. (2009). Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645. doi: 10.1161/circulationaha.109.192644">Ref</a>).</p>
	  <p>
	    Clinical thresholds exist for each of the markers. Different units are provided, where appropriate,
	    and alternate markers that are not in the guidelines, but may be used if no other data are available,
	    along with approximately equivalent thresholds.
	  </p>

	  <div class="table-responsive">
	    <table class="table table-striped">
	      <thead>
		<tr>
		  <th>&nbsp;</th>
		  <th>Females</th>
		  <th>Males</th>
		</tr>
	      </thead>
	      <tbody>
		<tr>
		  <th>Waist circumference</th>
		  <td>&ge; 80 cm (31 in) [~BMI &ge; 25]</td>
		  <td>&ge; 94 cm (37 in) [~BMI &ge; 25]
		  </td>
		</tr>
		<tr>
		  <th>Triglycerides</th>
		  <td>&ge; 1.7 mmol/L (150 mg/dL)</td>
		  <td>&ge; 1.7 mmol/L (150 mg/dL)</td>
		</tr>
		<tr>
		  <th>HDL Cholesterol</th>
		  <td>&lt; 1.3 mmol/L (50 mg/dL)</td>
		  <td>&lt; 1.0 mmol/L (40 mg/dL)</td>
		</tr>
		<tr>
		  <th scope="row">Hypertension</th>
		  <td>&ge; 130 mm Hg SBP and/or &ge; 85 mm Hg DBP</td>
		  <td>&ge; 130 mm Hg SBP and/or &ge; 85 mm Hg DBP</td>
		</tr>
		<tr>
		  <th>Fasting blood glucose</th>
		  <td>&ge; 5.6 mmol/L (100 mg/dL) [~HbA1c &ge; 5.7]</td>
		  <td>&ge; 5.6 mmol/L (100 mg/dL) [~HbA1c &ge; 5.7]</td>
		</tr>
	      </tbody>
	    </table>
	  </div>

      <div class="row">      
	<div class="col-sm-6">
	  
	  <p>In addition to the dichotomous presence or absence of the metabolic syndrome
	    condition, a metabolic syndrome "severity" or "symptom" score can be created,
	    by combining scores on individual biomarkers into a composite. Advantages of
	    such a composite is that it: 1) contains more information than the simple
	    metabolic syndrome present or absent dichotomy, and 2) is more sensitive to change,
	    which may be particularly important as a risk endpoint in intervention or
	    clinical trial research, and in clinical practice.  An individual may
	    improve substantially, even though she or he still meets criteria for
	    metabolic syndrome.
	  </p>

	  <p>The metabolic syndrome severity score (or MetSSS) can
	    be easily calculated using the cloud-based web app
	    below. This work is based on:</p>

	  <blockquote>
            <p>Wiley, J. F., &amp; Carrington, M. J. (in preparation).
              A metabolic syndrome severity score: A tool to quantify cardio-metabolic risk.</p>
	  </blockquote>

	  
	  <p>Note that when using this calculator, it is important to
	    specify the sex (Female or Male) for each set of values.
	    Systolic and diastolic blood pressure (SBP and DBP) should be
	    in mm Hg.  Triglycerides (Trigs), high density lipoprotein
	    cholesterol (HDL), and blood glucose (glucose) should be in
	    mmol/L.  Waist circumference (waist) should be in
	    centimeters.</p>

	<p>This chart is a histogram of the MetSSS score in a community sample of
	  adults in regional Australia from the Healthy Hearts
	  Study.</p> 

	</div>
	<div class="col-sm-6">
	  <div id = 'chart2c881c9341' class="rChart"></div>
	  <!-- <img class="center-block img-rounded img-responsive" -->
		    <!--      src="../score/HHMetSSS.png" style="width:100%;"> -->
		    <!-- <img class="center-block img-rounded img-responsive" -->
			      <!--      src="../score/HHMetSSS.svg" -->
			      <!--      alt="Histogram of metabolic syndrome severity scores in the healthy hearts study." -->
			      <!--      style="width:100% \9;"> -->
	</div>
	

	<iframe src="http://52.27.31.208/ocpu/library/webMetSSS/www/"
		style="bordern:none; width:100%; height:600px;">
	</iframe>      

      </div>

      
      <div class="row">      
	<h2 id="al">Allostatic Load</h2>
	<p>Allostatic load theory posits that repeated activation of the stress response
	  results in wear-and-tear on the body manifested through physiological dysregulation 
	  across the entire organism.  Examples of a "normal" stress response, healthy adaptation,
	  and then variants of non-optimal physiological stress responses are shown below.
	</p>
	
	<figure>
	  <img src="figs/stress.gif" alt="typical stress response" width="30%"></img>
	  <img src="figs/adapt.gif" alt="typical stress response" width="30%"></img>
	  <img src="figs/noadapt.gif" alt="typical stress response" width="30%"></img>	  
	  <img src="figs/norecover.gif" alt="typical stress response" width="30%"></img>
	  <img src="figs/noresponse.gif" alt="typical stress response" width="30%"></img>	  
	  <figcaption>From left to right, typical single physiological stress response--- reaction and recovery,
	    adaptive response - reactivity diminishes with repetition,
	    non-adaptive response - reactivity persists with repetition,
	    failure to recover - reactivity but no recovery,
	    failure to react - no reactivity.</figcaption>
	  
      </div>


      <div class="panel-group" id="accordion">
	<div class="panel panel-default" id="panel1">
	  <div class="panel-heading">
	    <h4 class="panel-title">
              &nbsp;&nbsp;<a data-toggle="collapse" data-target="#collapseOne" href="#collapseOne" class="collapsed">
		Example factor models for allostatic load
              </a>
	    </h4>
	  </div>
	  
	  <div id="collapseOne" class="panel-collapse collapse">
	    <div class="panel-body">
	      <object data="figs/al_sample_diagrams.svg" type="image/svg+xml" width="100%">
		<img src="figs/al_sample_diagrams.svg" alt="Example factor structure diagrams" width="100%"></img>
	      </object>	  
	    </div>
	  </div>
	</div>
	
	<div class="panel panel-default" id="panel2">
	  
	  <div class="panel-heading">
	    <h4 class="panel-title">
              &nbsp;&nbsp;<a data-toggle="collapse" data-target="#collapseTwo" href="#collapseTwo" class="collapsed">
		Sample fully specified factor models for allostatic load
              </a>
	    </h4>
	  </div>
	  
	  <div id="collapseTwo" class="panel-collapse collapse">
	    <div class="panel-body">
	      <object data="figs/biomarkers_full_diagrams.svg" type="image/svg+xml" width="100%" >
		<img src="figs/biomarkers_full_diagrams.svg" alt="Full biomarker factor structure diagrams" width="100%"></img>
	      </object>
	    </div>
	  </div>
	</div>
	
      </div>

      <h3><a id="methods" class="anchor" href="#methods"></a>Methods</h3>
      <p>There are many methods used to create biomarker composites. Examples include:
        <ul>
          <li>sum of biomarkers at or above a "risk" threshold</li>
          <li>sum of standardized biomarker scores (z-score and sum)</li>
          <li>latent factor(s) using factor analysis or structural equation models</li>
          <li>principal component analysis</li>
          <li>Mahalanobis distance (may be either from the mean or other normative values, the mean, or some other threshold)</li>
        </ul>
      </p>

      <p>
	In addition to each of these approaches to creating a composite, there are a
	number of additional considerations.  For example, when summing the number of
	biomarkers above a "risk" threshold, which threshold should be used? For some
	biomarkers, clinical guidelines exist, but for others no standards exist.
	When using the continuous biomarker scores, should the raw scores be used,
	or normalizing transformations performed?  Also, should the raw scores be used
	or should the deviations from clinical threshold be used?  If deviations are used,
	should scores "better" than the risk threshold be allowed, or only scores
	beyond the risk level be used?  Is it only values that are "too high" that are
	problematic or can biomarkers be too extreme in either direction, high or low?
      </p>
      <p>
	These are just some of the methodological decisions faced. Rather than
	leave leave these as subjective decisions, the SCORE Project
	aims to systematically evaluate different approaches, and provide
	empirical evidence to guide researchers and clinicians in
	making these decisions, as well as tools to facilitate creating the
	composite from whatever the decision.
      </p>

      <h3><a id="pubs" class="anchor" href="#pubs"></a>Publications</h3>

      <blockquote>
         <p>Wiley, J. F., Gruenewald, T., Karlamangla, A. &amp; Seeman, T. E. (under review).
         Modeling Multisystem Physiological Dysregulation.</p>
      </blockquote>

      <blockquote>
         <p>Wiley, J. F., &amp; Carrington, M. J. (in preparation).
         A metabolic syndrome severity score: A tool to quantify cardio-metabolic risk.</p>
      </blockquote>

      
      <p>
	Mplus input scripts to run the primary models from this paper, 
        as well as the Monte Carlo power simulation, and the 
        item parameter invariance models is available 
        <a href="https://github.com/JWiley/score-project/tree/master/Wiley_PsychMed_2015">
          online here</a>.
      </p>
      
      <h3><a id="software" class="anchor" href="#software"></a>Software</h3>

      <p>
	There is an <code>R</code> package called <code>pscore</code> to assist with the scoring and 
	creation of composites from biomarkers, available from this same GitHub repository.
      </p>
      <p>
	<a href="https://travis-ci.org/JWiley/score-project"><img src="https://travis-ci.org/JWiley/score-project.svg?branch=master" alt="Travis CI badge showing current build status"></img></a>
	<a href="http://cran.r-project.org/package=pscore"><img src="http://www.r-pkg.org/badges/version/pscore" alt="CRAN badge showing current package version on CRAN"></img></a>
      </p>
      
      <p>
	If you'd like to install the pscore package you can get the latest
	development version from GitHub or install the latest released
	version from CRAN using the code below.</p>
      <pre>
	# uncomment line below if devtools package not available
	# install.packages("devtools")
	library(devtools)
	install_github("JWiley/score-project/pscore") # latest development

	# From CRAN
	install.packages("pscore") # latest release
      </pre>
      <p>
	Currently, the package is focused on metabolic syndrome, but more
	will be coming soon to support scoring allostatic load.  Future work
	also aims to facilitate building/testing different scoring models,
        as well as getting predictions on new data from existing models.
      </p>


      <h3><a id="overview" class="anchor" href="#overview"></a>Project Roadmap &amp; Overview</h3>

      <object data="figs/score_overview.svg" type="image/svg+xml" width="100%" >
	<img src="figs/score_overview.svg" alt="Roadmap and overarching view of the SCORE Project" width="100%"></img>
      </object>
      
      
    </div>

      <footer class="footer">
	<div class="container">
          <p class="text-muted"><a href="https://github.com/JWiley/score-project">Score-project</a> is maintained by <a href="https://github.com/JWiley">JWiley</a> &nbsp; &copy; 2015 </p>
	</div>
      </footer>

  <script src="opencpu.js"></script>
  <script src="app.js"></script>
  <script src="d3.min.js"></script>
  <script src="nv.d3.min.js"></script>

    <script type='text/javascript'>
 $(document).ready(function(){
      drawchart2c881c9341()
    });
    function drawchart2c881c9341(){
      var opts = {
 "dom": "chart2c881c9341",
"width":    450,
"height":    450,
"x": "x",
"y": "Freq",
"group": "Gender",
"type": "multiBarChart",
"id": "chart2c881c9341"
},
        data = [
 {
 "CatMetSSS": "[0,0.5]",
"Gender": "Male",
"Freq": 81,
"x":           0.25
},
{
 "CatMetSSS": "(0.5,1]",
"Gender": "Male",
"Freq": 68,
"x":           0.75
},
{
 "CatMetSSS": "(1,1.5]",
"Gender": "Male",
"Freq": 88,
"x":           1.25
},
{
 "CatMetSSS": "(1.5,2]",
"Gender": "Male",
"Freq": 115,
"x":           1.75
},
{
 "CatMetSSS": "(2,2.5]",
"Gender": "Male",
"Freq": 92,
"x":           2.25
},
{
 "CatMetSSS": "(2.5,3]",
"Gender": "Male",
"Freq": 98,
"x":           2.75
},
{
 "CatMetSSS": "(3,3.5]",
"Gender": "Male",
"Freq": 86,
"x":           3.25
},
{
 "CatMetSSS": "(3.5,4]",
"Gender": "Male",
"Freq": 72,
"x":           3.75
},
{
 "CatMetSSS": "(4,4.5]",
"Gender": "Male",
"Freq": 66,
"x":           4.25
},
{
 "CatMetSSS": "(4.5,5]",
"Gender": "Male",
"Freq": 32,
"x":           4.75
},
{
 "CatMetSSS": "(5,5.5]",
"Gender": "Male",
"Freq": 28,
"x":           5.25
},
{
 "CatMetSSS": "(5.5,6]",
"Gender": "Male",
"Freq": 26,
"x":           5.75
},
{
 "CatMetSSS": "(6,6.5]",
"Gender": "Male",
"Freq": 11,
"x":           6.25
},
{
 "CatMetSSS": "(6.5,7]",
"Gender": "Male",
"Freq": 11,
"x":           6.75
},
{
 "CatMetSSS": "(7,7.5]",
"Gender": "Male",
"Freq": 1,
"x":           7.25
},
{
 "CatMetSSS": "(7.5,8]",
"Gender": "Male",
"Freq": 1,
"x":           7.75
},
{
 "CatMetSSS": "(8,8.5]",
"Gender": "Male",
"Freq": 0,
"x":           8.25
},
{
 "CatMetSSS": "(8.5,9]",
"Gender": "Male",
"Freq": 0,
"x":           8.75
},
{
 "CatMetSSS": "[0,0.5]",
"Gender": "Female",
"Freq": 154,
"x":           0.25
},
{
 "CatMetSSS": "(0.5,1]",
"Gender": "Female",
"Freq": 90,
"x":           0.75
},
{
 "CatMetSSS": "(1,1.5]",
"Gender": "Female",
"Freq": 121,
"x":           1.25
},
{
 "CatMetSSS": "(1.5,2]",
"Gender": "Female",
"Freq": 116,
"x":           1.75
},
{
 "CatMetSSS": "(2,2.5]",
"Gender": "Female",
"Freq": 151,
"x":           2.25
},
{
 "CatMetSSS": "(2.5,3]",
"Gender": "Female",
"Freq": 133,
"x":           2.75
},
{
 "CatMetSSS": "(3,3.5]",
"Gender": "Female",
"Freq": 104,
"x":           3.25
},
{
 "CatMetSSS": "(3.5,4]",
"Gender": "Female",
"Freq": 82,
"x":           3.75
},
{
 "CatMetSSS": "(4,4.5]",
"Gender": "Female",
"Freq": 76,
"x":           4.25
},
{
 "CatMetSSS": "(4.5,5]",
"Gender": "Female",
"Freq": 41,
"x":           4.75
},
{
 "CatMetSSS": "(5,5.5]",
"Gender": "Female",
"Freq": 47,
"x":           5.25
},
{
 "CatMetSSS": "(5.5,6]",
"Gender": "Female",
"Freq": 34,
"x":           5.75
},
{
 "CatMetSSS": "(6,6.5]",
"Gender": "Female",
"Freq": 15,
"x":           6.25
},
{
 "CatMetSSS": "(6.5,7]",
"Gender": "Female",
"Freq": 13,
"x":           6.75
},
{
 "CatMetSSS": "(7,7.5]",
"Gender": "Female",
"Freq": 5,
"x":           7.25
},
{
 "CatMetSSS": "(7.5,8]",
"Gender": "Female",
"Freq": 0,
"x":           7.75
},
{
 "CatMetSSS": "(8,8.5]",
"Gender": "Female",
"Freq": 1,
"x":           8.25
},
{
 "CatMetSSS": "(8.5,9]",
"Gender": "Female",
"Freq": 1,
"x":           8.75
}
]

      if(!(opts.type==="pieChart" || opts.type==="sparklinePlus" || opts.type==="bulletChart")) {
        var data = d3.nest()
          .key(function(d){
            //return opts.group === undefined ? 'main' : d[opts.group]
            //instead of main would think a better default is opts.x
            return opts.group === undefined ? opts.y : d[opts.group];
          })
          .entries(data);
      }

      if (opts.disabled != undefined){
        data.map(function(d, i){
          d.disabled = opts.disabled[i]
        })
      }

      nv.addGraph(function() {
        var chart = nv.models[opts.type]()
          .width(opts.width)
          .height(opts.height)
          .stacked(true)
          <!-- .showControls(false) -->

        if (opts.type != "bulletChart"){
          chart
            .x(function(d) { return d[opts.x] })
            .y(function(d) { return d[opts.y] })
        }


       d3.select("#" + opts.id)
        .append('svg')
        .datum(data)
        .transition().duration(500)
        .call(chart);

       nv.utils.windowResize(chart.update);
       return chart;
      });
    };
</script>



      
  </body>
</html>
